Pascal Furet

13.5k citations
130 papers · 9.1k · 1 hit paper · h-index 52

Impact in

  • Hematology top 0.5%
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • PI3K/AKT/mTOR signaling in cancer 23
    • Protein Kinase Regulation and GTPase Signaling 16
    • Chemical Synthesis and Analysis 16
    • Cancer-related Molecular Pathways 22
    • HER2/EGFR in Cancer Research 15

Pascal Furet

130 papers receiving 8.8k citations

Pascal Furet's Hit Papers

Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity 2008 · 993 citations
9930+6+12Years since publication250500750

Peers

Pascal Furet
Comparison fields: 5 of 134
  • Hematology 1.1k
  • Genetics 935
  • Oncology 2.3k
  • Molecular Biology 5.6k
  • Organic Chemistry 2.1k
Replace Thomas Meyer with:
Thomas Meyer Switzerland
Saul H. Rosenberg United States
David W. Fry United States
Charles Eigenbrot United States
Uwe Rix United States
Takao Yamori Japan
Adrian M. Senderowicz United States
Alex N. Bullock United Kingdom
Alexander J. Bridges United States
Liwu Fu China
Pascal Furet relative to Thomas Meyer Switzerland Thomas Meyer's profile →
Citations per field
00.5×3.5×
Thomas Meyer · 1×
Citations per year

Countries citing papers authored by Pascal Furet

Since Specialization
Citations

This map shows the geographic impact of Pascal Furet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Furet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Furet more than expected).

Fields of papers citing papers by Pascal Furet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Furet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Furet. The network helps show where Pascal Furet may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal Furet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal Furet Line = papers co-authored together Pascal Furet links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
Hit paper breakdown →
2008993
2 2004459
3 2011393
4 2013367
5 2001280
6 1995251
7 2006233
8 2000216
9 2002215
10 1997193
11 2003186
12 2009186
13 2015164
14 2000145
15 2004143
16 1996137
17 2002135
18 2004128
19 2003126
20 1990124

About Pascal Furet

Pascal Furet is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Hematology and Genetics, having authored 130 papers that have together received 9.1k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (23 papers), Cancer-related Molecular Pathways (22 papers), Chronic Myeloid Leukemia Treatments (21 papers), Protein Kinase Regulation and GTPase Signaling (16 papers), Chemical Synthesis and Analysis (16 papers), HER2/EGFR in Cancer Research (15 papers), Quinazolinone synthesis and applications (14 papers) and Chronic Lymphocytic Leukemia Research (14 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (935 citations), Oncology (2.3k citations), Molecular Biology (5.6k citations) and Organic Chemistry (2.1k citations). Pascal Furet has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Doriano Fabbro, Thomas Meyer, Patrick Chêne, Joseph Schoepfer, Carlos Garcı́a-Echeverrı́a, Giorgio Caravatti, Paul W. Manley, Elisabeth Buchdunger, Helmut Mett and Peter Traxler. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Cancer Research, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics and ACS Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact